The glucose-regulated protein 78 kDa (known as GRP78) is emerging as a target for cancer therapy and a biomarker for cancer prognosis. It is usually produced in greater quantities in cells that are under stress conditions. In many types of cancers, GRP78 protein has been observed to be produced in abnormally large quantities and it tends...
Tag: <span>Cancer Therapy</span>
Post
The bacteria in your gut could help determine if a cancer therapy will work
Why does cancer immunotherapy work for some patients, but not others? Gut biodiversity could play a decisive role, two new studies in Science suggest. A lush microbiome populated with “good bacteria” can boost the power of the treatments, one paper found. On the other hand, certain immunotherapies were less effective in patients who were taking...
Post
Bionic thymus: Artificial organ for pumping T cells for Cancer Treatment
Researchers have successfully used an artificial thymus to turn blood stem cells into T cells. The UCLA researchers have created an artificial organoid as a useful tool in reducing the time and cost of T cell immunotherapy for patients with a low count of WBC’s. Thymus– the organ located near the heart makes T cells...
Post
Defeating cancer using Gene regulation
Scientists are finding ways to put on and off genes as a means of battling cancer, which would eventually lead to highly personalized treatment for cancer at the genetic level. Such methods could shut down cancer’s defenses against medications. The code treatment; The molecular insight into our own DNA is now possible through a field...
Post
Team examines use of anti-parasitic drug as new treatment for brain tumors
Marc Symons, PhD, professor in The Feinstein Institute for Medical Research’s Karches Center for Oncology Research, is examining if a common medication administered to treat pinworms, could replace the current treatment used for certain brain cancers. These findings, which are published today in the Feinstein Institute Press’s peer-reviewed, open-access journal Molecular Medicine, could help to...
Post
“Sci-fi” cancer therapy fights brain tumors, study finds
In this March 29, 2017 photo, Joyce Endresen wears an Optune therapy device for brain cancer, as she speaks on a phone at work in Aurora, Ill. She was diagnosed in December 2014 with Glioblastoma. WASHINGTON — Although it sounds like science fiction, a cap-like device that makes electric fields to fight cancer improved survival for the first...
Post
Scientists develop new drug delivery method for cancer therapy
Research Associate Xiuling Li (left) and Associate Professor Christoph Rader led the study on the Florida campus of The Scripps Research Institute. (Photo by Junpeng Qi.) Scientists from the Florida campus of The Scripps Research Institute (TSRI) have developed a new drug delivery method that produces strong results in treating cancers in animal models,...
Post
Mesothelioma shows promising response to existing immunotherapy drug
An existing immunotherapy drug called pembrolizumab appears to be effective in the treatment of malignant pleural mesothelioma, a rare and aggressive lung cancer that is primarily caused by exposure to asbestos. Writing in The Lancet Oncology, researchers describe the first study to show a positive result from using the antibody drug against this rare cancer. Researchers...